Advertisement
AJPH
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


AJPH First Look, published online ahead of print Aug 13, 2008
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
AJPH.2007.122044v1
98/10/1865    most recent
Right arrow Submit a response
Right arrow purchase articles
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Right arrow Get other permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Wolfe, W. R.
Right arrow Articles by Heisler, M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Wolfe, W. R.
Right arrow Articles by Heisler, M.
Related Collections
Right arrow Community Health
Right arrow Epidemiology
Right arrow Global Health
Right arrow Access to Care
Right arrow HIV/AIDS
Right arrow Prevention
October 2008, Vol 98, No. 10 | American Journal of Public Health 1865-1871
© 2008 American Public Health Association
DOI: 10.2105/AJPH.2007.122044


RESEARCH AND PRACTICE

The Impact of Universal Access to Antiretroviral Therapy on HIV Stigma in Botswana

William R. Wolfe, MD, Sheri D. Weiser, MD, MPH, Karen Leiter, JD, MPH, Wayne T. Steward, PhD, MPH, Fiona Percy-de Korte, DPH, Nthabiseng Phaladze, PhD, Vincent Iacopino, MD, PhD and Michele Heisler, MD, MPA

At the time of the study, William Wolfe, Sheri Weiser, Karen Leiter, Fiona Percy-de Korte, Vincent Iacopino, and Michele Heisler were with Physicians for Human Rights, Cambridge, MA. William Wolfe was also with the Department of Psychiatry, University of California, San Francisco. Sheri Weiser and Wayne Steward were with the Center for AIDS Prevention Studies, University of California, San Francisco. Nthabiseng Phaladze was with the Department of Nursing, University of Botswana, Gaborone. Vincent Iacopino was affiliated with the Department of Medicine, University of Minnesota, Minneapolis. Michele Heisler was with the Veterans Affairs Ann Arbor Health System, Ann Arbor, MI, and the Department of Internal Medicine, University of Michigan School of Medicine, Ann Arbor.

Correspondence: Requests for reprints should be sent to William Wolfe, Posttraumatic Stress Disorder Program, Box 116P, SF Veterans Affairs Medical Center, 4150 Clement St, San Francisco, CA 94121 (e-mail: william.wolfe{at}ucsf.edu).

Objectives. We sought to examine the impact of treatment access on HIV stigma in Botswana 3 years after the introduction of a national program of universal access to antiretroviral therapy.

Methods. We studied the prevalence and correlates of HIV stigma in a population-based study of 1268 adults in Botswana in 2004. We used multivariate logistic regression to assess correlates of stigmatizing attitudes and a new measure, anticipated HIV stigma.

Results. Overall, 38% of participants had at least 1 stigmatizing attitude: 23% would not buy food from a shopkeeper with HIV; 5% would not care for a relative with HIV. Seventy percent reported at least 1 measure of anticipated stigma: 54% anticipated ostracism after testing positive for HIV, and 31% anticipated mistreatment at work. Perceived access to antiretroviral therapy was strongly and independently associated with decreased odds of holding stigmatizing attitudes (adjusted odds ratio [AOR] = 0.42; 95% confidence interval [CI] = 0.24, 0.74) and of anticipated stigma (AOR = 0.09; 95% CI = 0.03, 0.30).

Conclusions. Our findings suggest that antiretroviral therapy access may be a factor in reducing HIV stigma. Nevertheless, the persistence of stigmatizing attitudes and significant anticipated stigma suggest that HIV stigma must be a target for ongoing intervention.




This article has been cited by other articles:


Home page
AJPHHome page
A. Gamper, S. Nathaniel, and I. J. Robbe
UNIVERSAL ACCESS TO ANTIRETROVIRAL THERAPY AND HIV STIGMA IN BOTSWANA
Am J Public Health, June 1, 2009; 99(6): 968 - 969.
[Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2008 by the American Public Health Association